ARCHIVES

Clinton Administration Issues Research Misconduct Policy.

This article is from The Cancer Letter archive.

Vol. 26 No. 45 | December 8, 2000

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

September 26, 2003

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

October 4, 1985

Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer

September 23, 1994